Literature DB >> 18557724

Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys.

R N Smith1, T Kawai, S Boskovic, O Nadazdin, D H Sachs, A B Cosimi, R B Colvin.   

Abstract

The etiology of immunologically mediated chronic renal allograft failure is unclear. One cause is thought to be alloantibodies. Previously in Cynomolgus monkeys, we observed a relationship among donor-specific alloantibodies (DSA), C4d staining, allograft glomerulopathy, allograft arteriopathy and progressive renal failure. To define the natural history of chronic antibody-mediated rejection and its effect on renal allograft survival, we now extend this report to include 417 specimens from 143 Cynomolgus monkeys with renal allografts. A subset of animals with long-term renal allografts made DSA (48%), were C4d positive (29%), developed transplant glomerulopathy (TG) (22%) and chronic allograft arteriopathy (CAA) (19%). These four features were highly correlated and associated with statistically significant shortened allograft survival. Acute cellular rejection, either Banff type 1 or 2, did not correlate with alloantibodies, C4d deposition or TG. However, endarteritis (Banff type 2) correlated with later CAA. Sequential analysis identified four progressive stages of chronic antibody-mediated rejection: (1) DSA, (2) deposition of C4d, (3) TG and (4) rising creatinine/renal failure. These new findings provide strong evidence that chronic antibody-mediated rejection develops without enduring stable accommodation, progresses through four defined clinical pathological stages and shortens renal allograft survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18557724      PMCID: PMC2796366          DOI: 10.1111/j.1600-6143.2008.02303.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  87 in total

1.  Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates.

Authors:  T Kawai; S L Wee; H Bazin; D Latinne; J Phelan; S Boskovic; D S Ko; H Z Hong; S Mauiyyedi; O Nadazdin; G Abrahamian; F Preffer; R B Colvin; D H Sachs; A B Cosimi
Journal:  Transplantation       Date:  2000-07-27       Impact factor: 4.939

Review 2.  Antibody-mediated organ-allograft rejection.

Authors:  Robert B Colvin; R Neal Smith
Journal:  Nat Rev Immunol       Date:  2005-10       Impact factor: 53.106

3.  NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts.

Authors:  Shuichiro Uehara; Catharine M Chase; William H Kitchens; Harris S Rose; Robert B Colvin; Paul S Russell; Joren C Madsen
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

4.  Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates.

Authors:  R N Smith; T Kawai; S Boskovic; O Nadazdin; D H Sachs; A B Cosimi; R B Colvin
Journal:  Am J Transplant       Date:  2006-06-19       Impact factor: 8.086

5.  New evidence for a role of allograft accommodation in long-term tolerance.

Authors:  Jean Marie Heslan; Karine Renaudin; Pamela Thebault; Regis Josien; Maria-Cristina Cuturi; Elise Chiffoleau
Journal:  Transplantation       Date:  2006-11-15       Impact factor: 4.939

6.  ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment.

Authors:  Dorry L Segev; Christopher E Simpkins; Daniel S Warren; Karen E King; R Sue Shirey; Warren R Maley; J Keith Melancon; Matthew Cooper; Tomasz Kozlowski; Robert A Montgomery
Journal:  Am J Transplant       Date:  2005-10       Impact factor: 8.086

7.  Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries.

Authors:  Shamila Mauiyyedi; Patricia Della Pelle; Susan Saidman; A Bernard Collins; Manuel Pascual; Nina E Tolkoff-Rubin; Winfred W Williams; A Benedict Cosimi; Eveline E Schneeberger; Robert B Colvin
Journal:  J Am Soc Nephrol       Date:  2001-03       Impact factor: 10.121

8.  Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance/long-term observations in nonhuman primates.

Authors:  Svjetlan Boskovic; Tatsuo Kawai; Rex-Neal Smith; Siew-Lin Wee; Ognjenka Nadazdin; Ichiro Koyama; Susan Saidman; Francesca Cardarelli; Nahel Elias; Megan Sykes; Terry Strom; Robert B Colvin; David H Sachs; A Benedict Cosimi
Journal:  Transplantation       Date:  2006-09-27       Impact factor: 4.939

9.  Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome.

Authors:  Judith E Worthington; Anna McEwen; Lorna J McWilliam; Michael L Picton; Susan Martin
Journal:  Transplantation       Date:  2007-02-27       Impact factor: 4.939

10.  Incidence of positive C4d deposition in long-term survival cases over 10 yr after renal transplantation.

Authors:  Yukiomi Namba; Kazumasa Oka; Toshiki Moriyama; Masahiro Kyo; Ryoichi Imamura; Yi Shi; Naotsugu Ichimaru; Yoshitaka Isaka; Shiro Takahara; Akihiko Okuyama
Journal:  Clin Transplant       Date:  2006       Impact factor: 2.863

View more
  36 in total

1.  Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques.

Authors:  E K Page; A J Page; J Kwun; A C Gibby; F Leopardi; J B Jenkins; E A Strobert; M Song; R A Hennigar; N Iwakoshi; S J Knechtle
Journal:  Am J Transplant       Date:  2012-07-09       Impact factor: 8.086

Review 2.  Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant.

Authors:  Olivier Thaunat; Alice Koenig; Claire Leibler; Philippe Grimbert
Journal:  J Am Soc Nephrol       Date:  2016-02-12       Impact factor: 10.121

3.  Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys.

Authors:  Shahrooz S Kelishadi; Agnes M Azimzadeh; Tianshu Zhang; Tiffany Stoddard; Emily Welty; Christopher Avon; Mitch Higuchi; Amal Laaris; Xiang-Fei Cheng; Christine McMahon; Richard N Pierson
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

Review 4.  Antibody-mediated rejection: emergence of animal models to answer clinical questions.

Authors:  William M Baldwin; Anna Valujskikh; Robert L Fairchild
Journal:  Am J Transplant       Date:  2010-03-19       Impact factor: 8.086

Review 5.  Translational impact of NIH-funded nonhuman primate research in transplantation.

Authors:  Stuart J Knechtle; Julia M Shaw; Bernhard J Hering; Kristy Kraemer; Joren C Madsen
Journal:  Sci Transl Med       Date:  2019-07-10       Impact factor: 17.956

Review 6.  Chronic alloantibody mediated rejection.

Authors:  R Neal Smith; Robert B Colvin
Journal:  Semin Immunol       Date:  2011-11-02       Impact factor: 11.130

Review 7.  Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation.

Authors:  Zachary Fitch; Robin Schmitz; Jean Kwun; Bernhard Hering; Joren Madsen; Stuart J Knechtle
Journal:  Transplant Rev (Orlando)       Date:  2019-04-05       Impact factor: 3.943

Review 8.  Effect of antibodies on endothelium.

Authors:  X Zhang; E F Reed
Journal:  Am J Transplant       Date:  2009-09-22       Impact factor: 8.086

9.  Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.

Authors:  R Neal Smith; Fahim Malik; Nelson Goes; Alton B Farris; Emmanuel Zorn; Susan Saidman; Nina Tolkoff-Rubin; Sonika Puri; Waichi Wong
Journal:  Transpl Immunol       Date:  2012-08-30       Impact factor: 1.708

10.  Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Methods Mol Biol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.